Phage therapy

Jun 17, 2020

Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections

Jan 08, 2020

Adaptive Phage Therapeutics Awarded Initial Contract with Department of Defense

Jan 08, 2020

Locus Biosciences initiates world's first controlled clinical trial for a CRISPR enhanced bacteriophage therapy

Dec 04, 2019

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program

Oct 31, 2019

Armata Pharmaceuticals Issues Letter to Shareholders

Oct 15, 2019

Global Phage Therapy Market Report 2019 with Focus on the United States

Sep 30, 2019

BiomX Presents In Vivo Data on Bacteriophage Delivery to Intra-Tumor Bacteria

Aug 14, 2019

Armata Pharmaceuticals Announces Second Quarter Results and Provides Corporate and Clinical Update

Jun 11, 2019

BiomX Licenses Novel Targets for Liver Disease Phage Therapy Program From JSR Corporation in Japan

May 28, 2019

Armata Pharmaceuticals Announces Publication of Successful Adjunctive Phage Treatment in Cystic Fibrosis Patient